LeMaitre Vascular Quarterly Cash Flow Statement
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LeMaitre Vascular free cash flow
In the quarter ended Jun 30, 2026, LeMaitre Vascular generated $16.0 million of operating cash flow and spent $2.3 million on capital expenditures. That left free cash flow of $13.7 million, a free-cash-flow margin of 19.4% of revenue. Free cash flow was down 28.0% from the prior year's $18.9 million.
LeMaitre Vascular returned $5.7 million to shareholders: $5.7 million in dividends and $17,000 in share repurchases, equal to 42% of free cash flow. Free cash flow covered dividend payments 2.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
LeMaitre Vascular cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 17.05M | 15.68M | 15.58M | 17.36M | 13.78M | 11.01M | 11.18M | 11.14M | 11.83M | 9.89M | 8.46M | 7.50M |
| Net Income growth (YoY) | +23.74% | +42.39% | +39.32% | +55.84% | +16.51% | +11.37% | +32.12% | +48.51% | +46.04% | +63.69% | +50.44% | +37.50% |
| Depreciation & Amortization | 2.66M | 2.62M | 2.60M | 2.61M | 2.65M | 2.55M | 2.42M | 2.43M | 2.38M | 2.38M | 2.44M | 2.40M |
| Stock-Based Compensation | 1.94M | 2.09M | 2.10M | 1.74M | 1.94M | 2.05M | 1.74M | 1.61M | 1.61M | 1.61M | 1.40M | 1.31M |
| Change in Working Capital | -2.80M | -1.44M | -757.00K | 3.86M | -1.73M | -1.90M | -1.38M | -1.61M | -2.23M | -3.53M | -2.82M | 80.00K |
| Operating Cash Flow | 15.96M | 15.09M | 23.16M | 28.76M | 20.29M | 9.04M | 15.18M | 14.25M | 9.63M | 5.07M | 10.75M | 11.82M |
| Capital Expenditures | -2.31M | -2.78M | -1.78M | -2.28M | -1.34M | -1.38M | -2.04M | -1.67M | -1.88M | -1.37M | -1.28M | -1.05M |
| Investing Cash Flow | -11.08M | -13.12M | -16.82M | -27.45M | -16.35M | -4.32M | -173.89M | -12.86M | -11.00M | -2.36M | -2.26M | -9.85M |
| Dividends Paid | -5.72M | -5.71M | -4.54M | -4.54M | -4.52M | -4.52M | -3.60M | -3.60M | -3.59M | -3.59M | -3.12M | -3.12M |
| Share Repurchases | -17.00K | -460.00K | -1.22M | 0 | -4.00K | -601.00K | -1.35M | -1.00K | -7.00K | -358.00K | -667.00K | -5.00K |
| Financing Cash Flow | -5.05M | -3.22M | -3.59M | -2.95M | -2.76M | -5.24M | 164.08M | -3.15M | -2.87M | 39.00K | -2.69M | -3.12M |
| Net Change in Cash | -226.00K | -1.39M | 2.75M | -1.68M | 1.84M | -270.00K | 4.61M | -1.27M | -4.33M | 2.33M | 6.22M | -1.44M |
| Free Cash Flow | 13.65M | 12.31M | 21.38M | 26.48M | 18.95M | 7.66M | 13.14M | 12.58M | 7.75M | 3.70M | 9.47M | 10.77M |
This table shows 12 quarterly periods of LeMaitre Vascular's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LMAT's reporting calendar. What is a cash flow statement?